Chromatic pupillometry has been proposed as a tool to specifically evaluate melanopsin retinal ganglion cell (mRGC) dysfunction in some neurodegenerative disorders, particularly in Alzheimer’s disease (AD), as in AD the presence of retinal ganglion cell (RGC) loss has been already documented (Hinton et al., 1986; Curcio and Drucker, 1993) as well as the occurrence of abnormal circadian photoentrainment (La Morgia et al., 2017). This evidence concerns the gene OPN4 and early-onset autosomal dominant Alzheimer disease.